Delivery Order SPE2DB22D2006-SPE2DB25FW3WF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,343.16 on September 9, 2025, for Atovaquone-Proguanil 250-100 (100 tablets), with a completion date of September 10, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply needs. The order...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.16 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract, which is firm fixed price with an ultimate completion date of April 24, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.30 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial pharmaceutical is being procured through the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $12,312.30 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count). This firm fixed-price, non-set-aside delivery order was executed on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $25,275.80 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $44,740.80 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs the work at its corporate office location. The delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) valued at $2,350.53 under a firm fixed price contract. This antimalarial pharmaceutical product is being delivered to support military healthcare requirements, with the place of performance located in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,599.31 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in quantities of 100. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $31,675.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count). This contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a pharmaceutical supply delivery under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3WFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's SPE2DX contract enables it to supply a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. The antimalarial medication being delivered under this order supports the Defense Health Agency and other government healthcare systems. This delivery order represents one of numerous transactions executed under the prime contract vehicle, demonstrating AmerisourceBergen's capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 8/26/25 |